Global Transforming Growth Factor Beta 1 Market Growth 2025-2031

Global Transforming Growth Factor Beta 1 Market Growth 2025-2031

The global Transforming Growth Factor Beta 1 market size is predicted to grow from US$ 1758 million in 2025 to US$ 3381 million in 2031; it is expected to grow at a CAGR of 11.5% from 2025 to 2031.

Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene

North America is the largest Transforming Growth Factor Beta 1 market with about 69% market share. Europe is follower, accounting for about 16% market share.The key manufacturers are Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG etc.

LP Information, Inc. (LPI) ' newest research report, the “Transforming Growth Factor Beta 1 Industry Forecast” looks at past sales and reviews total world Transforming Growth Factor Beta 1 sales in 2024, providing a comprehensive analysis by region and market sector of projected Transforming Growth Factor Beta 1 sales for 2025 through 2031. With Transforming Growth Factor Beta 1 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transforming Growth Factor Beta 1 industry.

This Insight Report provides a comprehensive analysis of the global Transforming Growth Factor Beta 1 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Transforming Growth Factor Beta 1 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Transforming Growth Factor Beta 1 market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transforming Growth Factor Beta 1 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transforming Growth Factor Beta 1.

This report presents a comprehensive overview, market shares, and growth opportunities of Transforming Growth Factor Beta 1 market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Pirfenidone
Galunisertib
Others

Segmentation by Application:
IPF
Cancer
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche
Shionogi Ltd
Acceleron Pharma Inc
Genzyme Corp
Isarna Therapeutics GmbH
Scholar Rock
Sirnaomics Inc
Eli Lilly and Co
Formation Biologics Inc
Novartis AG

Key Questions Addressed in this Report

What is the 10-year outlook for the global Transforming Growth Factor Beta 1 market?

What factors are driving Transforming Growth Factor Beta 1 market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Transforming Growth Factor Beta 1 market opportunities vary by end market size?

How does Transforming Growth Factor Beta 1 break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.